ARTICLE | Clinical News
Boostrix regulatory update
May 9, 2005 7:00 AM UTC
FDA approved a BLA for Boostrix, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis booster vaccine, to treat bacterial infetions in individuals aged 10 to 18. ...